side effects glp 1 receptor agonists Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Agonists: A Multidisciplinary Expert Consensus GLP-1 Receptor Agonists as Treatments

Banji, and T

Preclinical and clinical data suggest that FXR and PPAR dual modulators can improve insulin sensitivity, reduce hepatic steatosis, and attenuate fibrosis, which may complement the actions of GLP-1/GIP/GCG receptors agonists

They work by mimicking the hormone, which is naturally released by the intestine after eating

Another study in a GIP receptor knockout model showed decreased bone strength and cortical thickness and increased bone resorptionbut paradoxically, an increased number of osteoblasts and a reduced number of osteoclasts [49]

Manufacturers can tailor formulations to supplement common deficiencies that GLP-1 agonist users may experience due to their altered diet